There are 122 resources available
Welcome and introduction
Presenter: Enrique Grande
Session: Merck Healthcare KGaA - Sequencing is Key: Unlocking Individualized Treatment in Bladder Cancer
Resources:
Webcast
Opening Remarks: Introduction to Healthcare System Readiness (HCS) Readiness for Radioligand Therapies (RLT) in Oncology
Presenter: Leonhard Schätz
Session: Novartis - Preparing for the future: Radioligand therapy as an essential pillar in oncology
Resources:
Webcast
Navigating first-line treatment approaches in la/mUC
Presenter: Alison Birtle
Session: Merck Healthcare KGaA - Sequencing is Key: Unlocking Individualized Treatment in Bladder Cancer
Resources:
Webcast
Panelists’ insights - Multi-stakeholder Perspectives on Overcoming Barriers to Establishing RLT in Oncology
Presenter: Leonhard Schätz, Ken Herrmann, Erik Briers, Elena Castro, Désirée Deandreis
Session: Novartis - Preparing for the future: Radioligand therapy as an essential pillar in oncology
Resources:
Webcast
Improving outcomes with first-line maintenance therapy and exploring patient selection
Presenter: Syed Hussain
Session: Merck Healthcare KGaA - Sequencing is Key: Unlocking Individualized Treatment in Bladder Cancer
Resources:
Webcast
Multi-Stakeholder Panel Discussion: A Multidisciplinary Approach to Navigating Challenges and Embracing Opportunities to Unlock HCS Readiness for RLT
Presenter: Leonhard Schätz, Ken Herrmann, Erik Briers, Elena Castro, Désirée Deandreis
Session: Novartis - Preparing for the future: Radioligand therapy as an essential pillar in oncology
Resources:
Webcast
Optimizing treatment sequencing: Learnings from Real-World Evidence and Clinical Experience
Presenter: Philippe Barthelemy
Session: Merck Healthcare KGaA - Sequencing is Key: Unlocking Individualized Treatment in Bladder Cancer
Resources:
Webcast
Open Forum: Q&A Session
Presenter: Leonhard Schätz, Ken Herrmann, Erik Briers, Elena Castro, Désirée Deandreis
Session: Novartis - Preparing for the future: Radioligand therapy as an essential pillar in oncology
Resources:
Webcast
Audience Q&A
Presenter: Enrique Grande, Syed Hussain, Philippe Barthelemy, Alison Birtle
Session: Merck Healthcare KGaA - Sequencing is Key: Unlocking Individualized Treatment in Bladder Cancer
Resources:
Webcast
Closing Session: Final Thoughts
Presenter: Leonhard Schätz, Ken Herrmann, Erik Briers, Elena Castro, Désirée Deandreis
Session: Novartis - Preparing for the future: Radioligand therapy as an essential pillar in oncology
Resources:
Webcast